Advisor Group Holdings, Inc. Co Diagnostics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 463 shares of CODX stock, worth $125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
463
Previous 12,425
96.27%
Holding current value
$125
Previous $9,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
5.72MCall Options Held
35.6KPut Options Held
25.9K-
Vanguard Group Inc Valley Forge, PA1.78MShares$480,1090.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$319,0400.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny550KShares$148,5860.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$135,5460.0% of portfolio
-
Geode Capital Management, LLC Boston, MA342KShares$92,3850.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $9.12M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...